PMGC Holdings Inc.
Datakwaliteit: 100%
ELAB
Nasdaq
Manufacturing
Chemicals
€ 5,26
▲
€ 0,76
(16,89%)
Marktkapitalisatie: 10,19 M
Prijs
€ 5,26
Marktkapitalisatie
10,19 M
Dagbereik
€ 5,25 — € 7,00
52-Weeksbereik
€ 1,62 — € 467,37
Volume
57.123.683
Openen € 6,53
50D / 200D Gem.
€ 8,38
37,22% below
50D / 200D Gem.
€ 100,59
94,77% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -6,38 M
Capital intensive — 74,95% of revenue goes to capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-88,35%
Onder sectorgemiddelde (-51,02%)
ROICN/A
Net Margin-1313,00%
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio1,79
Interest CoverageN/A
Waardering
PE (TTM)
-1,31
Boven sectorgemiddelde (-1,98)
P/B Ratio1,20
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (44 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (44 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,3 | -2,0 |
| P/B | 1,2 | 5,1 |
| ROE % | -88,4 | -51,0 |
| Net Margin % | -1313,0 | -150,2 |
| Rev Growth 5Y % | — | 9,3 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | -41,30% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 590.084,0 | Net Income (TTM) | -7,75 M |
| ROE | -88,35% | ROA | -63,73% |
| Gross Margin | 31,40% | Operating Margin | N/A |
| Net Margin | -1313,00% | Free Cash Flow (TTM) | -6,38 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,79 |
| Interest Coverage | N/A | Asset Turnover | 0,05 |
| Working Capital | 4,31 M | Tangible Book Value | 4,98 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1,31 | Forward P/E | N/A |
| P/B Ratio | 1,20 | P/S Ratio | 17,26 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -62,59% | ||
| Market Cap | 10,19 M | Enterprise Value | 10,19 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | 0,30 |
| FCF / Share | -3,29 | OCF / Share | -3,06 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 74,95% | FCF Conversion | 82,30% |
| SBC-Adj. FCF | -6,39 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 590.084,0 | — | 1,71 M |
| Net Income | -7,75 M | -6,25 M | -4,30 M |
| EPS (Diluted) | — | — | -0,40 |
| Gross Profit | 185.314,0 | — | 1,13 M |
| Operating Income | — | — | — |
| EBITDA | — | — | — |
| R&D Expenses | 147.010,0 | 104.654,0 | 426.243,0 |
| SG&A Expenses | — | — | — |
| D&A | 96.145,0 | — | — |
| Interest Expense | 103.294,0 | 735.197,0 | 19.525,0 |
| Income Tax | 30.972,0 | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 12,87 M | 8,99 M | 5,19 M |
| Total Liabilities | 5,03 M | 2,33 M | 1,36 M |
| Shareholders' Equity | 7,84 M | 6,66 M | 3,83 M |
| Total Debt | — | — | — |
| Cash & Equivalents | — | 3,98 M | — |
| Current Assets | 6,87 M | 6,05 M | 4,92 M |
| Current Liabilities | 3,94 M | 1,80 M | 1,30 M |
{"event":"ticker_viewed","properties":{"ticker":"ELAB","listing_kind":"stock","pathname":"/stocks/elab","exchange":"Nasdaq","country":"US"}}